Jiangsu Jiangshan Pharmaceutical Co

Founded in 1990 and based in Jingjiang City, Jiangsu Province, China, this manufacturer is one of the earliest Chinese enterprises devoted to the research and development, production and sale of Vitamin C series products, and ranks among the world's major ascorbic acid producers. The company operates a production base in Jingjiang with a corporate office in Suzhou, and has spent more than thirty years focused on a single specialty: the biosynthesis and downstream processing of Vitamin C and its salts and derivatives. The product line centers on Vitamin C (ascorbic acid) in crystalline and mesh-graded particle sizes, sodium ascorbate and sodium ascorbate in mesh grades, calcium ascorbate, and directly compressible granulated grades including Vitamin C granules (ascorbic acid DC), sodium ascorbate DC and calcium ascorbate DC. Additional developed items recognized as high-tech products by Jiangsu Province include coated ascorbic acid, L-ascorbate-2-carbonate, ascorbic acid at EP grade, low molecular weight heparin sodium, and high-purity sodium ascorbate. Standard ascorbic acid is supplied as a white or almost white crystalline powder or colourless crystals, packed 25 kg per carton and stored dry, away from light, heat and moisture. Materials are supplied into four principal end markets: pharmaceutical active ingredients for injections, tablets and effervescent tablets; food additives for purees, beverages, canned goods, milk powder and candy; feed additives for swine, poultry, cattle and aquaculture; and nutritional health products. The direct-compression granule grades in particular target tableting and effervescent applications where flow and compressibility matter, while the mesh grades allow customers to specify particle size for blending and dissolution behavior. Production and operations conform to GMP, ISO9001, FSSC22000, FAMI-QS, IP, Halal and Kosher quality system requirements. Products are made to meet the pharmacopoeia requirements of China, the United States, the European Union, the United Kingdom, Japan, Russia and India, along with FCC, E300 and other international standards - ChP, USP, FCC, BP and EP grades are all offered. This breadth of compendial coverage supports export across pharmaceutical, food and feed channels in multiple regulated markets. Research and development is treated as the core of the business. The company maintains a scientific research team and holds fourteen authorized invention patents covering its ascorbic acid chemistry and derivative products. Alongside catalog grades, its technical and R&D staff provide customized products and tailored solutions developed to customer specification, including purpose-built particle sizes, coated forms and application-specific formulations. The stated operating philosophy is 'Customer-first, Quality-oriented and Value-creation,' and the company positions itself as building a leading biosynthesis industry base serving global customers with higher-value Vitamin C products and services.